HPOL-B Stock Analysis: HEXPOL (publ) | ST
Specialty Chemicals | ST, Sweden | Market Cap: 30.896m SEK | 12M Return: 21.1% | SE0007074281 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.3M
EPS Trend: -98.2%
Qual. Beats: 0
Rev. Trend: -98.0%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HEXPOL AB (publ) is a Sweden-based polymer materials company that develops, manufactures, and sells polymer compounds, gaskets, seals, and wheels across Sweden, Europe, the Americas, and Asia. The company operates through two segments: HEXPOL Compounding, which produces rubber and thermoplastic elastomer compounds under multiple brands including HEXFLAME, Dryflex, Mediprene, and RheTech; and HEXPOL Engineered Products, which supplies finished gaskets and seals (Gislaved Gummi) and wheels (Stellana).
Its products serve a diverse range of end markets, including automotive, aerospace, construction, energy, oil and gas, consumer products, medical equipment, and agriculture. The company traces its origins to 1893, was previously named Hexagon Polymers AB, and adopted its current name in May 2008. It is headquartered in Malmö, Sweden.
Within the specialty chemicals sub-sector, HEXPOLs business model centers on custom-formulated polymer compounding-tailoring rubber and thermoplastic blends to customer specifications-supplemented by finished engineered components. The compounding model relies on close co-development with OEMs and tier suppliers, particularly in automotive, where rubber compounds are specified into vehicle platforms and create high switching costs once qualified.
- Automotive end-market demand drives Compounding segment volumes
- Raw material price volatility pressures polymer compound margins
- M&A pipeline targets expand specialty rubber footprint
| Net Income: 1.83b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.25 > 1.0 |
| NWC/Revenue: -6.30% < 20% (prev -5.41%; Δ -0.89% < -1%) |
| CFO/TA 0.11 > 3% & CFO 2.81b > Net Income 1.83b |
| Net Debt (4.19b) to EBITDA (3.26b): 1.29 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (344.4m) vs 12m ago 0.0% < -2% |
| Gross Margin: 21.04% > 18% (prev 21.07%; Δ -0.02% > 0.5%) |
| Asset Turnover: 76.19% > 50% (prev 82.36%; Δ -6.18% > 0%) |
| Interest Coverage Ratio: 24.94 > 6 (EBIT TTM 2.67b / Interest Expense TTM 107.0m) |
| A: -0.05 (Total Current Assets 7.99b - Total Current Liabilities 9.19b) / Total Assets 25.5b |
| B: 0.46 (Retained Earnings 11.8b / Total Assets 25.5b) |
| C: 0.11 (EBIT TTM 2.67b / Avg Total Assets 24.9b) |
| D: 1.30 (Book Value of Equity 14.4b / Total Liabilities 11.1b) |
| Altman-Z'' = 3.28 = A |
| DSRI: 1.11 (Receivables 3.89b/3.69b, Revenue 19.0b/20.0b) |
| GMI: 1.00 (GM 21.07% / 21.04%) |
| AQI: 0.96 (AQ_t 0.54 / AQ_t-1 0.56) |
| SGI: 0.95 (Revenue 19.0b / 20.0b) |
| TATA: -0.04 (NI 1.83b - CFO 2.81b) / TA 25.5b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of October 07, 2026, the stock is trading at SEK 97.05 with a total of 190,110 shares traded. Over the past week, the price has changed by +1.09%, over one month by +2.21%, over three months by +32.58% and over the past year by +21.14%.
Current recommended Stop Loss: 94.50 (which is 2.6% or 1.6 ATR below the current price).
HEXPOL (publ) has no consensus analysts rating.
P/E Trailing = 18.2075
P/E Forward = 14.1243
P/S = 1.7726
P/B = 2.3353
P/EG = 2.729
Revenue TTM = 19.0b SEK
EBIT TTM = 2.67b SEK
EBITDA TTM = 3.26b SEK
Long Term Debt = 338.0m SEK (from longTermDebtTotal, last fiscal year)
Short Term Debt = 5.03b SEK (from shortTermDebt, last quarter)
Debt = 5.80b SEK (from shortLongTermDebtTotal, last quarter) + Leases 428.0m
Net Debt = 4.19b SEK (calculated: Debt 5.80b - CCE 1.61b)
Enterprise Value = 35.1b SEK (30.9b + Debt 5.80b - CCE 1.61b)
Interest Coverage Ratio = 24.94 (Ebit TTM 2.67b / Interest Expense TTM 107.0m)
EV/FCF = 15.21x (Enterprise Value 35.1b / FCF TTM 2.31b)
FCF Yield = 6.58% (FCF TTM 2.31b / Enterprise Value 35.1b)
FCF Margin = 12.15% (FCF TTM 2.31b / Revenue TTM 19.0b)
Net Margin = 9.62% (Net Income TTM 1.83b / Revenue TTM 19.0b)
Gross Margin = 21.04% ((Revenue TTM 19.0b - Cost of Revenue TTM 15.0b) / Revenue TTM)
Gross Margin QoQ = 21.78% (prev 21.54%)
Tobins Q-Ratio = 1.37 (Enterprise Value 35.1b / Total Assets 25.5b)
Interest Expense / Debt = 1.84% (Interest Expense 107.0m / Debt 5.80b)
Taxrate = 27.40% (690.0m / 2.52b)
NOPAT = 1.94b (EBIT 2.67b * (1 - 27.40%))
Current Ratio = 0.87 (Total Current Assets 7.99b / Total Current Liabilities 9.19b)
Debt / Equity = 0.40 (Debt 5.80b / totalStockholderEquity, last quarter 14.4b)
Debt / EBITDA = 1.29 (Net Debt 4.19b / EBITDA 3.26b)
Debt / FCF = 1.82 (Net Debt 4.19b / FCF TTM 2.31b)
Total Stockholder Equity = 14.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.33% (Net Income 1.83b / Total Assets 25.5b)
RoE = 12.72% (Net Income TTM 1.83b / Total Stockholder Equity 14.4b)
RoCE = 18.14% (EBIT 2.67b / Capital Employed (Equity 14.4b + L.T.Debt 338.0m))
RoIC = 9.49% (NOPAT 1.94b / Invested Capital 20.4b)
WACC = 7.42% (E(30.9b)/V(36.7b) * Re(8.56%) + D(5.80b)/V(36.7b) * Rd(1.84%) * (1-Tc(0.27)))
Discount Rate = 8.56% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 49.75 | Cagr: 0.00%
[DCF] Terminal Value 76.42% ; FCFF base≈2.24b ; Y1≈2.40b ; Y5≈2.88b
[DCF] Fair Price = 121.3 (EV 44.2b - Net Debt 4.19b = Equity 40.0b / Shares 329.7m; r=8.35% [WACC [floored]]; 5y FCF grow 7.85% → 2.50% )
EPS Correlation: -98.17 | EPS CAGR: -13.42% | SUE: 0.76 | # QB: 0
Revenue Correlation: -98.05 | Revenue CAGR: -6.14% | SUE: 0.91 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.54 | Chg30d=-0.96% | Revisions=+57% | Analysts=4
EPS current Year (2026-12-31): EPS=6.11 | Chg30d=+0.02% | Revisions=+62% | GrowthEPS=+8.3% | GrowthRev=+2.9%
EPS next Year (2027-12-31): EPS=6.80 | Chg30d=+2.22% | Revisions=+62% | GrowthEPS=+11.4% | GrowthRev=+6.0%
[Analyst] Revisions Ratio: +82% (up=14, down=0)